Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAmiRNA is a biotech company specializing in the discovery and development of microRNA (miRNA) biomarkers for diagnostic and therapeutic applications. The company leverages its proprietary platform to identify miRNA signatures associated with aging-related diseases, including osteoporosis, cardiovascular disorders, and liver disease. TAmiRNA offers a range of diagnostic kits, such as osteomiR for bone health and hepatomiR for liver function, while also advancing a pipeline of miRNA-based therapeutic candidates. By integrating advanced transcriptomics with clinical data, the company aims to provide personalized medicine solutions that improve patient outcomes through early detection and targeted treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAmiRNA.